Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNECTICS PLC Board/Management Information 2022

Jun 1, 2022

7942_mang_2022-06-01_710fdb3c-cf4e-47bb-8ded-3be39601cf44.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4538N

Synectics PLC

01 June 2022

## RNS ## 1 June 2022

Synectics plc

("Synectics" or the "Company")

Director appointment

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, announces that it has appointed Andrew Lockwood as an independent Non-Executive Director with immediate effect.

Mr Lockwood has over 30 years' experience of reshaping and growing technology, managed services and healthcare businesses and is currently Chief Executive Officer of KCH Interventional Facilities Management LLP ("KFM"), a provider of healthcare support services. Prior to joining KFM, Andrew was Managing Director of Capita plc's international healthcare technology and services businesses, Commercial Director for data solutions at Daisy Communications Plc, Interim Chief Executive Office at Retalika Limited, a SaaS business, and President and co-founder of Graphita Inc, a web 2.0 online and mobile media and entertainment business. Previously, he had held various executive positions at Covad Communications, a provider of broadband and data services in the US, been Senior Vice President & General Manager, wireless at Inktomi Corporation, a software provider for internet service providers, and held various positions at BT.

Further information in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies ("AIM Rules") is set out at the end of this announcement.

David Coghlan, Chairman of Synectics, commented: "I am delighted to welcome Andy Lockwood to the Board of Synectics. Andy has had a distinguished career successfully growing enterprise software businesses with similar characteristics to Synectics' core activities. He will bring considerable personal energy and very relevant experience to our oversight of the Company's future growth path."

For further information, please contact:

Synectics plc Tel: +44 (0) 114 280 2828
David Coghlan, Chairman www.synecticsplc.com
email: [email protected]
Shore Capital Tel: +44 (0) 20 7408 4090
Tom Griffiths / David Coaten

About Synectics plc

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

INFORMATION REQUIRED UNDER SCHEDULE TWO, PARAGRAPH (G) OF THE AIM RULES

Save for the information set out below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules in respect of the appointment of Andrew Stephen Lockwood, aged 65. Mr Lockwood does not hold an interest in the Company's issued share capital.

Current Directorships Past Directorships
Bridgewalk Heights No31 Management Company Limited Bridgewalk Heights RTM Company Limited
CHKS Limited
Cymbio Limited

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUAOVRUUUVOAR